Analysts have been eager to weigh in on the Healthcare sector with new ratings on Argenx Se (ARGX) and Genfit SA (GNFT).
Argenx Se (ARGX)
Argenx Se received a Hold rating and a EUR200.00 price target from Kepler Capital analyst Damien Choplain on November 23. The company’s shares closed last Tuesday at $262.28, close to its 52-week high of $284.00.
Choplain has an average return of 69.4% when recommending Argenx Se.
According to TipRanks.com, Choplain is ranked #2737 out of 7112 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Argenx Se with a $275.07 average price target, representing a 4.8% upside. In a report released yesterday, H.C. Wainwright also maintained a Hold rating on the stock with a $265.00 price target.
See today’s analyst top recommended stocks >>
Genfit SA (GNFT)
In a report issued on November 23, Arsene Guekam from Kepler Capital maintained a Buy rating on Genfit SA, with a price target of EUR7.00. The company’s shares closed last Tuesday at $4.89, close to its 52-week low of $3.63.
According to TipRanks.com, Guekam is ranked #2315 out of 7112 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Genfit SA with a $8.16 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
